ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesChapter 1: Certain infectious and parasitic diseasesA30.2

A30.2

Billable

Leprosy, tuberculoid

Chapter 1:Certain infectious and parasitic diseases

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 A30.2 is a billable code used to indicate a diagnosis of leprosy, tuberculoid.

Key Diagnostic Point:

Leprosy, also known as Hansen's disease, is a chronic infectious disease caused by the bacterium Mycobacterium leprae. Tuberculoid leprosy is one of the two major forms of the disease, characterized by a strong immune response that limits the spread of the bacteria. Patients typically present with a few well-defined skin lesions that are hypopigmented and may be numb due to peripheral nerve damage. The lesions are often accompanied by a loss of sensation and can lead to significant disability if not treated. Diagnosis is primarily clinical, supported by skin smears and biopsies that may reveal the presence of M. leprae. Treatment involves multi-drug therapy (MDT) with rifampicin and dapsone, which is effective in curing the disease and preventing transmission. Tuberculoid leprosy is less contagious than lepromatous leprosy, and patients usually have a better prognosis. However, early diagnosis and treatment are crucial to prevent complications and disability.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Differentiation between tuberculoid and lepromatous leprosy
  • Need for accurate clinical documentation of symptoms and lesions
  • Potential for co-infection with other mycobacterial diseases
  • Variability in presentation and immune response among patients

Audit Risk Factors

  • Inadequate documentation of clinical findings
  • Failure to document treatment adherence and response
  • Misclassification of leprosy type
  • Lack of follow-up documentation

Specialty Focus

Medical Specialties

Infectious Disease

Documentation Requirements

Detailed clinical notes on symptoms, laboratory results, and treatment plans.

Common Clinical Scenarios

Diagnosis and management of leprosy, monitoring treatment response, and managing complications.

Billing Considerations

Ensure accurate coding based on clinical findings and laboratory confirmation.

Dermatology

Documentation Requirements

Photographic evidence of skin lesions, detailed descriptions of lesions, and sensory testing results.

Common Clinical Scenarios

Evaluation of skin lesions, differential diagnosis of skin conditions, and management of leprosy-related skin issues.

Billing Considerations

Document the extent of nerve involvement and sensory loss for accurate coding.

Coding Guidelines

Inclusion Criteria

Use A30.2 When
  • Follow the official ICD
  • CM coding guidelines for infectious diseases, ensuring accurate documentation of the type of leprosy and any associated complications
  • Include relevant laboratory results and clinical findings to support the diagnosis

Exclusion Criteria

Do NOT use A30.2 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

36415CPT Code

Skin biopsy

Clinical Scenario

Used to confirm diagnosis of leprosy when skin lesions are present.

Documentation Requirements

Document the location of the biopsy, findings, and rationale for the procedure.

Specialty Considerations

Ensure that the biopsy is performed by a qualified specialist.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of leprosy types, improving data accuracy and treatment tracking. It has also facilitated better understanding of disease epidemiology and resource allocation.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of leprosy types, improving data accuracy and treatment tracking. It has also facilitated better understanding of disease epidemiology and resource allocation.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of leprosy types, improving data accuracy and treatment tracking. It has also facilitated better understanding of disease epidemiology and resource allocation.

Resources

Clinical References

  • •
    World Health Organization - Leprosy

Coding & Billing References

  • •
    World Health Organization - Leprosy

Frequently Asked Questions

What is the primary treatment for tuberculoid leprosy?

The primary treatment for tuberculoid leprosy is multi-drug therapy (MDT) which typically includes rifampicin and dapsone. Treatment duration is usually 6 months.